Friday, December 19, 2014

I.P.O. of Juno Therapeutics, Developer of a Cancer Treatment, Excites Investors by ANDREW POLLACK



By ANDREW POLLACK


A little-known year-old company, which counts Jeff Bezos as an early investor, pulled off one of the largest initial public stock offerings in the biotechnology sector.


Published: December 19, 2014 at 12:00AM


from NYT Business Day http://ift.tt/1xwzf9s






from WordPress http://ift.tt/1HcJ7Vy

via Hadi Aboukhater
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)